Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
PDB DOI: 10.2210/pdb4c4e/pdb
Classification: TRANSFERASE Organism(s): Homo Sapiens
Deposited: 2013-09-05 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1
Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.
Primary Citation of Related Structures: 4C4E
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
DUAL SPECIFICITY PROTEIN KINASE TTK | A | 313 | Homo Sapiens | MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE |
Method: X-RAY DIFFRACTION
Deposited Date: 2013-09-05 Deposition Author(s): Atrash, B. , Baker, R. , Bavetsias, V. , Blagg, J. , Boxall, K. , Burke, R. , Choi, V. , De Haven Brandon, A. , Eccles, S.A. , Faisal, A. , Gurden, M. , Hayes, A. , Henley, A. , Linardopoulos, S. , Liu, M. , Mak, G. , Matijssen, B. , Mcandrew, C. , Naud, S. , Raynaud, F.I. , Schmitt, J. , Sheldrake, P. , Valenti, M. , Van Montfort, R. , Westwood, I.M. , Wood, A.